Korro Bio, Inc. Long-term Purchase Commitment, Amount
Korro Bio, Inc. (KRRO) reported Long-term Purchase Commitment, Amount of $600.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2022-03-15
- Korro Bio, Inc. long-term purchase commitment, amount for the quarter ending 2021-12-31 was $0.00.
- Korro Bio, Inc. long-term purchase commitment, amount for the quarter ending 2021-09-30 was $0.00.
- Korro Bio, Inc. long-term purchase commitment, amount for the quarter ending 2021-06-30 was $0.00.
- Korro Bio, Inc. long-term purchase commitment, amount for the quarter ending 2021-03-31 was $600.00K, a 14.89% decline year-over-year.
- Korro Bio, Inc. long-term purchase commitment, amount for fiscal 2021 was $600.00K, a 0.00% change from fiscal 2020.
- Korro Bio, Inc. long-term purchase commitment, amount for fiscal 2020 was $600.00K, a 14.89% decline from fiscal 2019.
- Korro Bio, Inc. long-term purchase commitment, amount for fiscal 2019 was $705.00K.
| Period end | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 derived: sum of 3 quarters · filed 2022-03-15 | $600.00K 10-K · filed 2022-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $600.00K 10-Q · filed 2021-11-15 | $600.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $600.00K 10-Q · filed 2021-08-12 | $600.00K derived: sum of 3 quarters · filed 2021-08-12 | $495.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $600.00K 10-Q · filed 2021-05-13 | $600.00K derived: sum of 2 quarters · filed 2021-05-13 | $495.00K derived: sum of 3 quarters · filed 2021-05-13 | $495.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$105.00K derived: sum of 2 quarters · filed 2021-03-29 | -$105.00K derived: sum of 3 quarters · filed 2021-03-29 | $600.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | -$105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$105.00K derived: sum of 2 quarters · filed 2020-11-16 | $600.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $705.00K 10-Q · filed 2020-08-12 | ||
| 2020-03-31 | $705.00K 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | $705.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |